How much funding has Ark raised?

Ark has raised $10.7M in total funding, most recently a Series A round.

Who are Ark's investors?

Ark's investors include The Engine, Lowercase Capital, Night Ventures, Hawktail, BioTools Innovator.

Where is Ark headquartered?

Ark is headquartered in Boston, Massachusetts, United States.

What industry is Ark in?

Ark operates in Artificial Intelligence, Biotech, SaaS.

Ark

Ushering in the era of Computational Bioprocess

Boston, United States · Founded 2021 · $10.7M raised

Artificial Intelligence

Biotech

SaaS

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: ark-biotech.com
Total Funding: $10.7M
Last Round: $8.2M Series AJan 2023
Rounds: 2

About

Ark Biotech is a Boston-based computational bioprocess software company that provides an AI-powered platform enabling biopharma companies and CDMOs to simulate, optimize, and scale bioprocesses dramatically faster than traditional methods. The platform allows scientists to run virtual bioreactor experiments in seconds, simulate thousands of process variations to find optimal parameters, and scale up manufacturing first time right — without requiring coding or special data formats. Top biopharma companies and CDMOs trust Ark to shorten development timelines, reduce bioreactor runs, improve titer and process robustness, and achieve SOC 2 Type II certified secure operations.

Summary

Ark is an Artificial Intelligence company based in Boston, United States, founded in 2021. It has raised $10.7M in total across 2 rounds, most recently a $8.2M Series A round in Jan 2023. Investors include The Engine, Lowercase Capital and Night Ventures.